Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports First Quarter 2023 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 25.95 +0.71 (2.81%)
Previous Close $25.24    52 Week High
Open $25.54    52 Week Low
Day High $26.03    P/E N/A 
Day Low $25.06    EPS
Volume 1,111,195